Literature DB >> 6317140

Peripheral neuropathy in Tangier disease.

M Pollock, H Nukada, R W Frith, J P Simcock, S Allpress.   

Abstract

Peripheral nerve morphometry was assessed in four patients with Tangier disease. Three patients with a relapsing and remitting multiple mononeuropathy had prominent peripheral nerve demyelination and remyelination with affected internodes clustered along particular nerve fibres. Putative lipid vacuoles were almost exclusively confined in this multifocal neuropathy syndrome to Remak cells. By contrast a fourth patient with a slowly progressive syringomyelia-like neuropathy had advanced peripheral nerve degeneration and a more global distribution of lipid vacuoles within peripheral nerve. A review of Tangier disease in the literature indicated the possibility of additional peripheral nerve syndromes. The clinical heterogeneity raises the possibility of different metabolic errors in Tangier disease or a common metabolic error subject to genetic influences. The results of this study indicate that normal serum cholesterol levels do not exclude a diagnosis of Tangier disease. It is therefore advisable to determine both high density lipoproteins and serum cholesterol levels in patients with undiagnosed multifocal neuropathy or syringomyelia-like syndromes.

Entities:  

Mesh:

Year:  1983        PMID: 6317140     DOI: 10.1093/brain/106.4.911

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  9 in total

1.  Tangier neuropathy in Italy.

Authors:  V Pietrini
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 2.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

3.  Clinical and electrophysiological characteristics of neuropathy associated with Tangier disease.

Authors:  Julie Zyss; Anthony Béhin; Philippe Couvert; Françoise Bouhour; Agnès Sassolas; Ivan Kolev; Violaine Denys; Christophe Vial; A Lacour; Alain Carrié; Tanya Stojkovic
Journal:  J Neurol       Date:  2011-12-17       Impact factor: 4.849

4.  The ABCA1 cholesterol transporter associates with one of two distinct dystrophin-based scaffolds in Schwann cells.

Authors:  Douglas E Albrecht; Diane L Sherman; Peter J Brophy; Stanley C Froehner
Journal:  Glia       Date:  2008-04-15       Impact factor: 7.452

5.  Acute presentation of Tangier polyneuropathy: a clinical and morphological study.

Authors:  R Fazio; R Nemni; A Quattrini; G Ruotolo; S Iannaccone; D Mamoli; M Lodi; N Canal
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Tangier disease. A case with sensorimotor distal polyneuropathy and lipid accumulation in striated muscle and vasa nervorum.

Authors:  A Marbini; F Gemignani; G Ferrarini; S Maccari; B Lucci; M M Bragaglia; C Plancher; C Vergani
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies.

Authors:  E Gibbels; H E Schaefer; U Runne; J M Schröder; W F Haupt; G Assmann
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

8.  A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation.

Authors:  Marco Ceccanti; Chiara Cambieri; Vittorio Frasca; Emanuela Onesti; Antonella Biasiotta; Carla Giordano; Sabina M Bruno; Giancarlo Testino; Marco Lucarelli; Marcello Arca; Maurizio Inghilleri
Journal:  Front Neurol       Date:  2016-11-02       Impact factor: 4.003

9.  Effects of miglustat treatment in a patient affected by an atypical form of Tangier disease.

Authors:  Annalisa Sechi; Andrea Dardis; Stefania Zampieri; Claudio Rabacchi; Paolo Zanoni; Sebastiano Calandra; Giovanna De Maglio; Stefano Pizzolitto; Valerio Maruotti; Antonio Di Muzio; Frances Platt; Bruno Bembi
Journal:  Orphanet J Rare Dis       Date:  2014-09-18       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.